Funding of an individual investigator can be found in the member links to their home pages. The following programmatic grant and activities relate specifically to the activities initiated through the IAADR.
| 1R01DA022370: | Mechanisms of Carisoprodol Abuse |
| 2 P01 AG022550: | Mechanisms of Cognitive Decline During Aging |
| 1 R01 AG027353: | Brain Aging and Antioxidant Supplementation |
| N01DA-7-8872: | Rodent Drug Discrimination and Locomotor Activity Testing for NIDA |
| BK-1736: | Structure Determination of a Chloride Ion Channel to Atomic Resolution |
| R01 AA01582: | Effects of Age on Ethanol Withdrawal Toxicity: Mechanisms and Therapy |
| 1R21AA018747: | Intermittent Hypoxia Protects Brain from Ethanol Withdrawal: Mechanisms and Therapy |
| 1R01DA029840: | PET Radiotracers for Imaging the Dopamine D3 Receptor |
| 1 R21 MH081281: | Dopamine D2 Selective Imaging Agents |
| 1 R01DA023957: | D3 Receptor Compounds for the Treatment of Psychostimulant Abuse |
| 1R21AG031421: | Novel Molecular Probes for Membrane Progesterone Receptors |
| 1P01AG027956: | Novel Mechanistic Targets of Steroid Hormones in the Brain |
| 1 P20 MD001633: | Role of Ethnicity in the Features of Hot Flashes in Menopausal Women |
| 2 T32 AG020494: | Training in the Neurobiology of Aging |
| W81XWH-10-2-0003: | Vision Integrating Strategies in Opthalmology and Neurochemistry (VISION) |
| IIRG-07-59767: | Progestin-regulated Neurotrophin Synthesis and Release in Neuroprotection |
| 10BGIA4180116: | The Role of Androgens and Oxidative Stress in Dopamine Neurons |
| 2R01NS00039951: | Gonadal Steroid Receptors and the Hypothalamo- Pituitary-Adrenal Axis |
| 1 R01 MH082900: | GR-mediated Epigenetic Regulation of the CRH Gene |
| Nestle Sponsored: | Assessment of Nestle Diet on Long-Term Outcome after Ischemic Stroke in Female (Phase 4A) and Male Rats (Phase 4B) |
| 1 R01 NS054687: | Interaction of Estrogen and Tissue Plasminogen Activator |
| Nestle Sponsored: | Assessment of the Effects of Nestle Diets in an Alzheimer's Disease Model in Female (Phase 5A) and Male Mouse (Phase 5B) |
| 4R33NS052850: | Computational Optical Tomography for Anti-stroke Therapy |
| 1R01NS054651: | Vascular Cognitive Impairment Induced by Ischemic Stroke: Mechanism and Therapy |
| 1 R01 EY016242: | Glucocorticoids, Ocular Hypertension and Glaucoma" |